Core Insights - Quest Diagnostics reported strong revenue growth of approximately 12% in Q1 2025, driven by demand recovery and contributions from acquisitions [2][7] - The company reaffirmed its revenue and adjusted EPS guidance for the full year 2025 [2] Financial Performance - Net revenues for Q1 2025 were 2.652billion,upfrom2.366 billion in Q1 2024, representing a 12.1% increase [2][12] - Diagnostic Information Services revenues increased by 12.7% to 2.589billion[2][12]−Operatingincomeroseto346 million, a 15.4% increase from 300millioninthepreviousyear[2][12]−NetincomeattributabletoQuestDiagnosticswas220 million, up 13.2% from 194million[2][12]−DilutedEPSforQ12025was1.94, reflecting a 12.8% increase from 1.72inQ12024[2][12]OperationalMetrics−Requisitionvolumeincreasedby12.410.70 billion and 10.85billion,indicatinganincreaseof8.48.62 to 8.87,whileadjusteddilutedEPSremainsbetween9.55 and 9.80[3][7]−Cashprovidedbyoperationsisanticipatedtobeapproximately1.5 billion, with capital expenditures around 500million[3]CashFlowandCapitalExpenditures−CashprovidedbyoperationsinQ12025was314 million, a significant increase of 103.4% from 154millioninQ12024[2][16]−Capitalexpendituresforthequarterwere117 million, up 11.9% from 104million[2][16]BalanceSheetHighlights−AsofMarch31,2025,totalassetswere15.797 billion, down from 16.153billionattheendof2024[14]−Currentliabilitiesdecreasedto1.441 billion from 2.169billion[14]−Totalstockholders′equityincreasedto6.962 billion from $6.813 billion [14]